Nutritional recommendations for cardiovascular disease prevention

Nutrients

Volumn 5, Issue 9, 2013, Pages 3646-3683

  Eilat Adar, Sigal ^a   Sinai, Tali ^b   Yosefy, Chaim ^c,d   Henkin, Yaakov ^d,e  

^a WINGATE INSTITUTE   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c Cardiology Department   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cardiovascular; Guidelines; Nutrition; Prevention

Indexed keywords

ANTIOXIDANT; CAFFEINE; FISH OIL; MAGNESIUM; OMEGA 3 FATTY ACID; PHYTOSTEROL; SODIUM; SODIUM CHLORIDE; UBIDECARENONE; VITAMIN D;

ALCOHOLIC BEVERAGE; CACAO; CARDIOVASCULAR DISEASE; COFFEE; DAIRY PRODUCT; DIET; DIET SUPPLEMENTATION; DIETARY FIBER; DISEASE ASSOCIATION; EGG; FOOD; FRUIT; GARLIC; GRAIN; HUMAN; LIFESTYLE; LOW CARBOHYDRATE DIET; LOW FAT DIET; MEDITERRANEAN DIET; NUT; NUTRITION; NUTRITIONAL REQUIREMENT; REVIEW; SOYBEAN; TEA; VEGETABLE;

ALLIUM SATIVUM;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; DIET, MEDITERRANEAN; DIETARY FIBER; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FOOD HABITS; FRUIT; HUMANS; LIFE STYLE; META-ANALYSIS AS TOPIC; MICRONUTRIENTS; NUTRITIONAL STATUS; NUTS; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMMENDED DIETARY ALLOWANCES; SODIUM CHLORIDE, DIETARY; VEGETABLES;

EID: 84884563913     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu5093646     Document Type: Review

References (167)

1. Rydén, L.; Stand, L.E.; Bartnik, M.; van den Berghe, G.; Betteridge, J.; de Boer, M.J.; Cosentino, F.; Jönsson, B.; Laakso, M.; Malmberg, K.; et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur. Heart J. 2007, 28, 88-136.
2. Perk, J.; de Backer, G.; Gohlke, H.; Graham, I.; Reiner, Z.; Verschuren, M.; Albus, C.; Benlian, P.; Boysen, G.; Cifkova, R.; et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2012, 33, 1635-1701.
3. American Heart Association Nutrition Committee; Lichtenstein, A.H.; Appel, L.J.; Brands, M.; Carnethon, M.; Daniels, S.; Franch, H.A.; Franklin, B.; Kris-Etherton, P.; Harris, W.S.; et al. Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114, 82-96.
4. Hooper, L.; Summerbell, C.D.; Thompson, R.; Sills, D.; Roberts, F.G.; Moore, H.J.; Davey Smith, G. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst. Rev. 2012, 5, CD002137.
5. Hite, A.H.; Berkowitz, V.G.; Berkowitz, K. Low-carbohydrate diet review: Shifting the paradigm. Nutr. Clin. Pract. 2011, 26, 300-308.
6. Nordmann, A.J.; Nordmann, A.; Briel, M.; Keller, U.; Yancy, W.S., Jr.; Brehm, B.J.; Bucher, H.C. Effects of low-carbohydrate vs. low-fat diets on weight loss and cardiovascular risk factors. A meta-analysis of randomized controlled trials. Arch. Intern. Med. 2006, 166, 285-293.
7. Santos, F.L.; Esteves, S.S.; da Costa Pereira, A.; Yancy, W.S., Jr.; Nunes, J.P. Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes. Rev. 2012, 13, 1048-1066.
8. Shai, I.; Schwarzfuchs, D.; Henkin, Y.; Shahar, D.R.; Witkow, S.; Greenberg, I.; Golan, R.; Fraser, D.; Bolotin, A.; Vardi, H.; et al. Weight loss with a low-carbohydrate, mediterranean, or low-fat diet. N. Engl. J. Med. 2008, 359, 229-241.
9. Trichopoulou, A.; Lagiou, P. Healthy traditional Mediterranean diet: An expression of culture, history, and lifestyle. Nutr. Rev. 1997, 55, 383-389.
10. Kris-Etherton, P.; Eckel, R.H.; Howard, B.V.; St Jeor, S.; Bazzarre, T.L.; Nutrition Committee Population Science Committee and Clinical Science Committee of the American Heart Association. AHA Science Advisory: Lyon diet heart study. Benefits of a mediterranean-style, national cholesterol education program/american heart association step I dietary pattern on cardiovascular disease. Circulation 2001, 103, 1823-1825.
11. Sofi, F.; Abbate, R.; Gensini, G.F.; Casini, A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: An updated systematic review and meta-analysis. Am. J. Clin. Nutr. 2010, 92, 1189-1196.
12. Estruchm, R.; Rosm, E.; Salas-Salvadó, J.; Covas, M.I.; Corella, D.; Arós, F.; Gómez-Gracia, E.; Ruiz-Gutiérrez, V.; Fiol, M.; Lapetra, J.; et al. Primary revention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 2013, 368, 1279-1290.
13. Appel, L.J.; Moore, T.J.; Obarzanek, E.; Vollmer, W.M.; Svetkey, L.P.; Saeks, F.M.; Bray, G.A.; Vogt, T.M.; Cutler, J.A.; Windhauser, M.M.; et al. The effect of dietary patterns on blood pressure: Results from the Dietary Approaches to Stop Hypertension trial. N. Engl. J. Med. 1997, 336, 1117-1124.
14. Sacks, F.M.; Obarzanek, E.; Windhauser, M.M.; Svetkey, L.P.; Vollmer, W.M.; McCullough, M.; Karanja, N.; Lin, P.H.; Steele, P.; Proschan, M.A.; et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH): A multicenter controlled feeding study of dietary patterns to lower blood pressure. Ann. Epidemiol. 1995, 5, 108-118.
15. Appel, L.J.; Champagne, C.M.; Harsha, D.W.; Cooper, L.S.; Obarzanek, E.; Elmer, P.J.; Stevens, V.J.; Vollmer, W.M.; Lin, P.H.; Svetkey, L.P.; et al. Effects of comprehensive lifestyle modification on blood pressure control: Main results of the premier clinical trial. JAMA 2003, 289, 2083-2093.
16. Sacks, F.M.; Svetkey, L.P.; Vollmer, W.M.; Appel, L.J.; Bray, G.A.; Harsha, D.; Obarzanek, E.; Conlin, P.R.; Miller, E.R., III; Simons-Morton, D.G.; et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N. Engl. J. Med. 2001, 344, 3-10.
17. Blumenthal, J.A.; Babyak, M.A.; Hinderliter, A.; Watkins, L.L.; Craighead, L.; Lin, P.H.; Caccia, C.; Johnson, J.; Waugh, R.; Sherwood, A. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: The ENCORE study. Arch. Intern. Med. 2010, 170, 126-135.
18. Maruthur, N.M.; Wang N.Y.; Appel, L.J. Lifestyle interventions reduce coronary heart disease risk: Results from the PREMIER trial. Circulation 2009, 119, 2026-2031.
19. Shai, I.; Spence, J.D.; Schwarzfuchs, D.; Henkin, Y.; Parraga, G.; Rudich, A.; Fenster, A.; Mallett, C.; Liel-Cohen, N.; Tirosh, A.; et al. Dietary intervention to reverse carotid atherosclerosis. Circulation 2010, 121, 1200-1208.
20. De Moura, F.F.; Lewis, K.D.; Falk, M.C. Applying the FDA definition of whole grains to the evidence for cardiovascular disease health claims. J. Nutr. 2009, 139, 2220S-2226S.
21. Prosky, L. When is dietary fiber considered a functional food? Biofactors 2000, 12, 289-297.
22. Slavin, J.L. Position of the American Dietetic Association: Health implications of dietary fiber. J. Am. Diet. Assoc. 2008, 108, 1716-1731.
23. Kelly, S.A.; Summerbell, C.D.; Brynes, A.; Whittaker, V.; Frost, G. Wholegrain cereals for coronary heart disease. Cochrane Database Syst. Rev. 2007, 18, CD005051.
24. Brown, L.; Rosner, B.; Willett, W.W.; Sacks, F.M. Cholesterol-lowering effects of dietary fiber: A meta-analysis. Am. J. Clin. Nutr. 1999, 69, 30-42.
25. Marlett, J.A.; McBurney, M.I.; Slavin, J.L.; American Dietetic Association. Position of the American Dietetic Association: Health implications of dietary fiber. J. Am. Diet. Assoc. 2002, 102, 993-1000.
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285, 2486-2497.
27. Food and Drug Administration, HHS. Food labeling: Health claims; soluble fiber from certain foods and risk of coronary heart disease. Interim final rule. Fed. Regist. 2008, 25, 9938-9947.
28. Pennington, J.A.T.; Fisher, R.A. Classification of fruits and vegetables. J. Food. Compos. Anal. 2009, 22, S23-S31.
29. Dauchet, L.; Amouyel, P.; Hercberg, S.; Dallongeville, J. Fruit and vegetable consumption and risk of coronary heart disease: A meta-analysis of cohort studies. J. Nutr. 2006, 136, 2588-2593.
30. Van Horn, L.; McCoin, M.; Kris-Etherton, P.M.; Burke, F.; Carson, J.A.; Champagne, C.M.; Karmally, W.; Sikand, G. The evidence for dietary prevention and treatment of cardiovascular disease. J. Am. Diet. Assoc. 2008, 108, 287-331.
31. Brufau, G.; Boatella, J.; Rafecas, M. Nuts, source of energy and macronutrients. Br. J. Nutr. 2006, 96, S24-S28.
32. Ros, E.; Mataix, J. Fatty acid composition of nuts-Implications for cardiovascular health. Br. J. Nutr. 2006, 96, S29-S35.
33. Emilio, R. Health Benefits of Nut Consumption. Nutrients 2010, 2, 652-682.
34. Sabaté, J.; Ang, Y. Nuts and health outcomes: New epidemiologic evidence. Am. J. Clin. Nutr. 2009, 89, 1643S-1648S.
35. Kris-Etherton, P.M.; Hu, F.B.; Ros, E.; Sabaté, J. The role of tree nuts and peanuts in the prevention of coronary heart disease: Multiple potential mechanisms. J. Nutr. 2008, 138, 1746S-1751S.
36. Sabaté, J.; Oda, K.; Ros, E. Nut consumption and blood lipid levels: A pooled analysis of 25 intervention trials. Arch. Intern. Med. 2010, 170, 821-827.
37. Kristen, S.; Montgomery, J. Soy protein. Perinat. Educ. 2003, 12, 42-45.
38. Pitkin, J. Alternative and complementary therapies for the menopause. Menopause Int. 2012, 18, 20-27.
39. Hooper, L.; Kroon, P.A.; Rimm, E.B.; Cohn, J.S.; Harvey, I.; Le Cornu, K.A.; Ryder, J.J.; Hall, W.L.; Cassidy, A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2008, 88, 38-50.
40. Food labeling: Health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS, Final rule. Fed. Regist. 1999, 64, 57700-57733.
41. Micha, R.; Wallace, S.K.; Mozaffarian, D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: A systematic review and meta-analysis. Circulation 2010, 121, 2271-2283.
42. Dong, J.Y.; Qin, L.Q. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: A meta-analysis of prospective studies. Breast Cancer Res. Treat. 2011, 125, 315-323.
43. Jakobsen, M.U.; O'Reilly, E.J.; Heitmann, B.L.; Pereira, M.A.; Bälter, K.; Fraser, G.E.; Goldbourt, U.; Hallmans, G.; Knekt, P.; Liu, S.; et al. Major types of dietary fat and risk of coronary heart disease: A pooled analysis of 11 cohort studies. Am. J. Clin. Nutr. 2009, 89, 1425-1432.
44. Elwood, P.C.; Pickering, J.E.; Givens, D.I.; Gallacher, J.E. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: An overview of the evidence. Lipids 2010, 45, 925-939.
45. Soedamah-Muthu, S.S.; Ding, E.L.; Al-Delaimy, W.K.; Hu, F.B.; Engberink, M.F.; Willett, W.C.; Geleijnse, J.M. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: Dose-response meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2011, 93, 158-171.
46. Eilat-Adar, S.; Xu, J.; Loria, C.; Mattil, C.; Goldbourt, U.; Howard, B.V.; Resnick, H.E. Dietary calcium is associated with body mass index and body fat in American Indians. J. Nutr. 2007, 137, 1955-1960.
47. Tholstrup, T. Dairy products and cardiovascular disease. Curr. Opin. Lipidol. 2006, 17, 1-10.
48. German, J.B.; Gibson, R.A.; Krauss, R.M.; Nestel, P.; Lamarche, B.; van Staveren, W.A.; Steijns, J.M.; de Groot, L.C.; Lock, A.L.; Destaillats, F. A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur. J. Nutr. 2009, 48, 191-203.
49. Hu, F.B.; Stampfer, M.J.; Manson, J.E.; Ascherio, A.; Colditz, G.A.; Speizer, F.E.; Hennekens, C.H.; Willett, W.C. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am. J. Clin. Nutr. 1999, 70, 1001-1008.
50. Marmoy, M.; Brunner, E. Alcohol and cardiovascular disease: The status of the U-shaped curve. BMJ 1991, 303, 565-568.
51. Ronksley, P.E.; Brien, S.E.; Turner, B.J.; Mukamal, K.J.; Ghali, W.A. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. BMJ 2011, 342, d671.
52. Goldberg, I.J.; Mosca, L.; Piano, M.R.; Fisher, E.A.; Nutrition Committee; Council on Epidemiology and Prevention; Council on Cardiovascular Nursing of the American Heart Association. AHA Science Advisory: Wine and your heart: A science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation 2001, 103, 472-475.
53. Marmot, M.G. Alcohol and coronary heart disease. Int. J. Epidemiol. 2001, 30, 724-729.
54. Mukamal, K.L.; Maclure, M.; Muller, J.E.; Mittleman, M.A. Binge drinking and mortality after acute myocardial infarction. Circulation 2005, 112, 3839-3845.
55. Costanzo, S.; di Castelnuovo, A.; Donati, M.B.; Lacoviello, L.; de Gaetano, G. Cardiovascular and overall mortality risk in relation to alcohol consumption in patients with cardiovascular disease. Circulation 2010, 4, 1951-1959.
56. Corrao, G.; Rubbiati, L.; Bagnardi, V.; Zambon, A.; Poikolainen, K. Alcohol and coronary heart disease: A meta-analysis. Addiction 2000, 95, 1505-1523.
57. Corrao, G.; Bagnardi, V.; Zambon, A.; La Vecchia, C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev. Med. 2004, 38, 613-619.
58. Brien, S.E.; Ronksley, P.E.; Turner, B.J.; Mukamal, K.J.; Ghali, W.A. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: Systematic review and meta-analysis of interventional studies. BMJ 2011, 342, d636.
59. Kloner, R.A.; Rezkalla, S.H. To drink or not to drink? That is the question. Circulation 2007, 116, 1306-1317.
60. Seitz, H.K.; Pelucchi, C.; Bagnardi, V.; La Vecchia, C. Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012. Alcohol Alcohol. 2012, 47, 204-212.
61. USDA National Nutrient Database for Standard Reference. Available online: http://www.nal.usda.gov/fnic/foodcomp/search/ (accessed on 7 September 2012).
62. Cornelis, M.C.; El-Sohemy, A. Coffee, caffeine, and coronary heart disease. Curr. Opin. Lipidol. 2007, 18, 13-19.
63. LaCroix, A.Z.; Mead, L.A.; Liang, K.Y.; Thomas, C.B.; Pearson, T.A. Coffee consumption and the incidence of coronary heart disease. N. Engl. J. Med. 1986, 16, 977-982.
64. Jick, H.; Miettinen, O.S.; Neff, R.K.; Shapiro, S.; Heinonen, O.P.; Slone, D. Coffee and myocardial infarction. N. Engl. J. Med. 1973, 289, 63-67.
65. Silletta, M.G.; Marfisi, R.; Levantesi, G.; Boccanelli, A.; Chieffo, C.; Franzosi, M.; Geraci, E.; Maggioni, A.P.; Nicolosi, G.; Schweiger, C.; et al. Coffee consumption and risk of cardiovascular events after acute myocardial infarction: Results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial. Circulation 2007, 116, 2944-2951.
66. Mesas, A.E.; Leon-Muñoz, L.M.; Rodriguez-Artalejo, F.; Lopez-Garcia, E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2011, 94, 1113-1126.
67. Di Castelnuovo, A.; di Giuseppe, R.; Iacoviello, L.; de Gaetano, G. Consumption of cocoa, tea and coffee and risk of cardiovascular disease. Eur. J. Intern. Med. 2012, 23, 15-25.
68. De Koning Gans, J.M.; Uiterwaal, C.S.; van der Schouw, Y.T.; Boer, J.M.; Grobbee, D.E.; Verschuren, W.M.; Beulens, J.W. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 1665-1671.
69. Sugiyama, K.; Kuriyama, S.; Akhter, M.; Kakizaki, M.; Nakaya, N.; Ohmori-Matsuda, K.; Shimazu, T.; Nagai, M.; Sugawara, Y.; Hozawa, A.; et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J. Nutr. 2010, 140, 1007-1013.
70. Muley, A.; Muley, P.; Shah, M. Coffee to reduce risk of type 2 diabetes? A systematic review. Curr. Diabetes Rev. 2012, 8, 162-168.
71. Higdon, J.V.; Frei, B. Coffee and health: A review of recent human research. Crit. Rev. Food Sci. Nutr. 2006, 46, 101-123.
72. Khan, N.; Mukhtar, H. Tea polyphenols for health promotion. Life Sci. 2007, 81, 519-533.
73. Clement, Y. Can green tea do that? A literature review of the clinical evidence. Prev. Med. 2009, 49, 83-87.
74. Kuriyama, S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J. Nutr. 2008, 138, 1548S-1553S.
75. Wang, Z.M.; Zhou, B.; Wang, Y.S.; Gong, Q.Y.; Wang, Q.M.; Yan, J.J.; Gao, W.; Wang, L.S. Black and green tea consumption and the risk of coronary artery disease: A meta-analysis. Am. J. Clin. Nutr. 2011, 93, 506-515.
76. Arab, L.; Liu, W.; Elashoff, D. Green and black tea consumption and risk of stroke: A meta-analysis. Stroke 2009, 40, 1786-1792.
77. Deka, A.; Vita, J.A. Tea and cardiovascular disease. Pharmacol. Res. 2011, 64, 36-145.
78. Brown, M.D. Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Altern. Med. Rev. 1999, 4, 360-370.
79. Schönthal, A.H. Adverse effects of concentrated green tea extracts. Mol. Nutr. Food. Res. 2011, 55, 874-885.
80. Cooper, K.A.; Donovan, J.L.; Waterhouse, A.L.; Williamson, G. Cocoa and health: A decade of research. Br. J. Nutr. 2008, 99, 1-11.
81. Ding, E.L.; Hutfless, S.M.; Ding, X.; Girotra, S. Chocolate and prevention of cardiovascular disease: A systematic review. Nutr. Metab. (Lond.) 2006, 3, doi:10.1186/1743-7075-3-2.
82. Buitrago-Lopez, A.; Sanderson, J.; Johnson, L.; Warnakula, S.; Wood, A.; di Angelantonio, E.; Franco, O.H. Chocolate consumption and cardiometabolic disorders: Systematic review and meta-analysis. BMJ 2011, 343, d4488.
83. Messerli, F.H. Chocolate consumption, cognitive function, and nobel laureates. N. Engl. J. Med. 2012, 367, 1562-1564.
84. Fernández-Murga, L.; Tarín, J.J.; García-Perez, M.A.; Cano, A. The impact of chocolate on cardiovascular health. Maturitas 2011, 69, 312-321.
85. Rahman, K.; Lowe, G.M. Garlic and cardiovascular disease: A critical review. J. Nutr. 2006, 136, 736S-740S.
86. Tattelman, E. Health effects of garlic. Am. Fam. Phys. 2005, 7, 103-106.
87. Reinhart, K.M.; Talati, R.; White, C.M.; Coleman, C.I. The impact of garlic on lipid parameters: A systematic review and meta-analysis. Nutr. Res. Rev. 2009, 22, 39-48.
88. Khoo, Y.S.; Aziz, Z. Garlic supplementation and serum cholesterol: A meta-analysis. J. Clin. Pharm. Ther. 2009, 34, 133-145.
89. Ackermann, R.T.; Mulrow, C.D.; Ramirez, G.; Gardner, C.D.; Morbidoni, L.; Lawrence, V.A. Garlic shows promise for improving some cardiovascular risk factors. Arch. Intern. Med. 2001, 161, 813-824.
90. Kritchevsky, S.B.; Kritchevsky, D. Egg consumption and coronary heart disease: An epidemiologic overview. J. Am. Coll. Nutr. 2000, 19, 549S-555S.
91. Jones, P.J. Dietary cholesterol and the risk of cardiovascular disease in patients: A review of the Harvard Egg Study and other data. Int. J. Clin. Pract. Suppl. 2009, 63, 28-36.
92. USDA Food Tables. Available online: http://ndb.nal.usda.gov/ndb/foods/show/111?fg=Dairy+ and+Egg+Products&man=&lfacet=&format=&count=&max=25&offset=100&sort=&qlookup= (accessed on 27 October 2012).
93. Dawber, T.R.; Nickerson, R.J.; Brand, F.N.; Pool, J. Eggs, serum cholesterol, and coronary heart disease. Am. J. Clin. Nutr. 1982, 36, 617-625.
94. Qureshi, A.I.; Suri, F.K.; Ahmed, S.; Nasar, A.; Divani, A.A.; Kirmani, J.F. Regular egg consumption does not increase the risk of stroke and cardiovascular diseases. Med. Sci. Monit. 2007, 13, CR1-CR8.
95. Hu, F.B.; Stampfer, M.J.; Rimm, E.B.; Manson, J.E.; Ascherio, A.; Colditz, G.A.; Rosner, B.A.; Spiegelman, D.; Speizer, F.E.; Sacks, F.M.; et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 1999, 281, 1387-1394.
96. Djoussé, L.; Gaziano, J.M. Egg consumption and risk of heart failure in the Physicians' Health Study. Circulation 2008, 117, 512-516.
97. Djoussé, L.; Gaziano, J.M. Egg consumption in relation to cardiovascular disease and mortality: The Physicians' Health Study. Am. J. Clin. Nutr. 2008, 87, 964-969.
98. Djoussé, L.; Gaziano, J.M.; Buring, J.E.; Lee, I.M. Egg consumption and risk of type 2 diabetes in men and women. Diabetes Care 2009, 32, 295-300.
99. Weggemans, R.M.; Zock, P.L.; Katan, M.B. Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: A meta-analysis. Am. J. Clin. Nutr. 2001, 73, 885-891.
100. Glatz, J.F.; Turner, PR.; Katan, M.B.; Stalenhoef, A.F.; Lewis, B. Hypo-and hyperresponse of serum cholesterol level and low density lipoprotein production and degradation to dietary cholesterol in man. Ann. N. Y. Acad. Sci. 1993, 676, 163-179.
101. He, F.J.; MacGregor, G.A. Effect of modest salt reduction on blood pressure: A meta-analysis of randomized trials: Implications for public health. J. Hum. Hypertens. 2002, 16, 761-770.
102. Taylor, R.S.; Ashton, K.E.; Moxham, T.; Hooper, L.; Ebrahim, S. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2011, 7, CD009217.
103. IOM Committee Report on Sodium Intake in Populations. Available online: http://www.iom.edu/Reports/2013/Sodium-Intake-in-Populations-Assessment-of-Evidence.aspx (accessed on 25 August 2013).
104. Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G.; Gluud, C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2012, 3, CD007176.
105. Honarbakhsh, S.; Schachter, M. Vitamins and cardiovascular disease. Br. J. Nutr. 2009, 101, 1113-1131.
106. Sesso, H.D.; Christen, W.G.; Bubes, V.; Smith, J.P.; MacFadyen, J.; Schvartz, M.; Manson, J.E.; Glynn, R.J.; Buring, J.E.; Gaziano, J.M. Multivitamins in the prevention of cardiovascular disease in men: The Physicians' Health Study II randomized controlled trial. JAMA 2012, 708, 751-760.
107. Holick, M.F. Evidence-based D-bate on health benefits of Vitamin D revisited. Dermato-endocrinology 2012, 4, 83-90.
108. Holick, M.D. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
109. Sokol, S.I.; Tsang, P.; Aggarwal, V.; Melamed, M.L.; Srinivas, V.S. Vitamin D status and risk of cardiovascular events: Lessons learned via systematic review and meta-analysis. Cardiol. Rev. 2011, 19, 192-201.
110. Grandi, N.C.; Breitling, L.P.; Brenner, H. Vitamin D and cardiovascular disease: Systematic review and meta-analysis of prospective studies. Prev. Med. 2010, 51, 228-233.
111. Wang, L.; Song, Y.; Manson, J.E.; Pilz, S.; März, W.; Michaëlsson, K.; Lundqvist, A.; Jassal, S.K.; Barrett-Connor, E.; Zhang, C.; et al. Circulating 25-hydroxy-vitamin d and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 2012, 5, 819-829.
112. Pittas, A.G.; Chung, M.; Trikalinos, T.; Mitrim, J; Brendel, M.; Patel, K.; Lichtenstein, A.H.; Lau, J.; Balk, E.M. Systematic review: Vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 2010, 152, 307-314.
113. Esposti, M.D.; Ngo, A.; Ghelli, A.; Benelli, B.; Carelli, V.; McLennan, H.; Linnane, A.W. The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria. Arch. Biochem. Biophys. 1996, 330, 395-400.
114. Ernster, L.; Dallner, G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1995, 1271, 195-204.
115. McMurray, J.J.V.; Dunselman, P.; Wedel, H.; Cleland, J.G.F.; Lindberg, M.; Hjalmarson, A.; Kjekshus, J.; Waagstein, F.; Apetrei, E.; Barrios, V.; et al. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure. J. Am. Coll. Cardiol. 2010, 56, 1196-1204.
116. Overvad, K.; Diamant, B.; Holm, L.; Holmer, G.; Mortensen, S.A.; Stender, S. Coenzyme Q10 in health and disease. Eur. J. Clin. Nutr. 1999, 53, 764-770.
117. Sander, S.; Coleman, C.I.; Patel, A.A.; Kluger, J.; White, C.M. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J. Card. Fail. 2006, 12, 464-472.
118. Gao, L.; Mao, Q.; Cao, J.; Wang, Y.; Zhou, X.; Fan, L. Effects of coenzyme Q10 on vascular endothelial function in humans: A meta-analysis of randomized controlled trials. Atherosclerosis 2012, 221, 311-316.
119. Ho, M.J.; Bellusci, A.; Wright, J.M. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst. Rev. 2009, 4, CD007435.
120. Vandenberg, B.F.; Robinson, J. Management of the patient with statin intolerance. Curr. Atheroscler. Rep. 2010, 12, 48-57.
121. Bookstaver, D.A.; Burkhalter, N.A.; Hatzigeorgiou, C. Effect of coenzyme Q10 supplementation on statin-induced myalgias. Am. J. Cardiol. 2012, 110, 526-529.
122. Supplements. National Institutes of Health. Available online: http://ods.od.nih.gov/factsheets/ magnesium.asp (accessed on 19 January 2010).
123. Seelig, M.S.; Rosanoff, A. The Magnesium Factor; Avery: New York, NY, USA, 2003.
124. Liao, F.; Folsom, A.R.; Brancati, F.L. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) study. Am. Heart J. 1998, 136, 480-490.
125. Schulze, M.B.; Schulz, M.; Heidemann, C.; Schienkiewitz, A.; Hoffmann, K.; Boeing, H. Fiber and magnesium intake and incidence of type 2 diabetes. A prospective study and meta-analysis. Arch. Intern. Med. 2007, 167, 956-965.
126. Shechter, M. Magnesium and cardiovascular system. Magnes. Res. 2010, 23, 1-13.
127. He, K.; Liu, K.; Daviglus, M.L.; Loria, C.M.; Van Horn, L.; Jacobs, D.R., Jr.; Savage, P.J. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006, 113, 1675-1682.
128. Shechter, M. Magnesium and cardiovascular system. Magnes. Res. 2010, 23, 60-72.
129. Stepura, O.B.; Martynow, A.I. Magnesium orotate in severe congestive heart failure (MACH). Int. J. Cardiol. 2009, 131, 293-295.
130. Shechter, M.; Sharir, M.; Labrador, M.; Forrester, J.; Silver, B.; Bairey Merz, C.N. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000, 102, 2353-2358.
131. Shechter, M.; Bairey Merz, C.N.; Paul-Labrador, M.; Meisel, S.R.; Rude, R.K.; Molloy, M.D.; Dwyer, J.H.; Shah, P.K.; Kaul, S. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am. J. Cardiol. 1999, 84, 152-156.
132. Kark, J.D.; Selhub, J.; Adler, B.; Gofin, J.; Abramson, J.H.; Friedman, G.; Rosenberg, I.H. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in jerusalem. Ann. Intern. Med. 1999, 131, 321-330.
133. Wolff, T.; Witkop, C.T.; Miller, T.; Syed, S.B. Folic acid supplementation for the prevention of neural tube defects: An update of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2009, 150, 632-639.
134. Eilat-Adar, S.; Goldbourt, U. Nutritional recommendations for preventing coronary heart disease in women: Evidence concerning whole foods and supplements. Nutr. Metab. Cardiovasc. Dis. 2010, doi:10.1016/j.numecd.2010.01.011.
135. Bønaa, K.H.; Njølstad, I.; Ueland, P.M.; Schirmer, H.; Tverdal, A.; Steigen, T.; Wang, H.; Nordrehaug, J.E.; Arnesen, E.; Rasmussen, K.; et al. Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction. N. Engl. J. Med. 2006, 354, 1578-1588.
136. Lee, M.; Hong, K.S.; Chang, S.C.; Saver, J.L. Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: A meta-analysis. Stroke 2010, 41, 1205-1212.
137. Jardine, M.J.; Kang, A.; Zoungas, S.; Navaneethan, S.D.; Ninomiya, T.; Nigwekar, S.U.; Gallagher, M.P.; Cass, A.; Strippoli, G.; Perkovic, V. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: Systematic review and meta-analysis. BMJ 2012, 344, e3533.
138. Plourde, M.; Cunnane, S.C. Extremely limited synthesis of long chain polyunsaturates in adults: Implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. 2007, 32, 619-634.
139. Neubronner, J.P.; Schuchardt, G.; Kressel, G.; Merkel, M.; von Schacky, C.; Hahn, A.L. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur. J. Clin. Nutr. 2011, 65, 247-254.
140. Kris-Etherton, P.M.; Harris, W.S.; Appel, L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106, 2747-2757.
141. Grønbaek, M. Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur. J. Clin. Nutr. 1999, 53, 585-590.
142. Bucher, H.C.; Hengstler, P.; Schindler, C.; Meier, G. N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials. Am. J. Med. 2002, 112, 298-304.
143. Studer, M.; Briel, M.; Leimenstoll, B.; Glass, T.R.; Bucher, H.C. Effect of different antilipidemic agents and diets on mortality: A systematic review. Arch. Intern. Med. 2005, 165, 725-730.
144. Rauch, B.; Schiele, R.; Schneider, S.; Diller, F.; Victor, N.; Gohlke, H.; Gottwik, M.; Steinbeck, G.; del Castillo, U.; Sack, R.; et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified Omega-3 Fatty Acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010, 122, 2152-2159.
145. Bosch, J.; Gerstein, H.C.; Dagenais, G.R.; Díaz, R.; Dyal, L.; Jung, H.; Maggiono, A.P.; Probstfield, J.; Ramachandran, A.; Riddle, M.C. N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N. Engl. J. Med. 2012, 367, 309-318.
146. Kromhout, D.; Giltay, E.J.; Geleijnse, J.M. N-3 fatty acids and cardiovascular events after myocardial infarction. N. Engl. J. Med. 2010, 363, 2015-2026.
147. Galan, P.; Kesse-Guyot, E.; Czernichow, S.; Briancon, S.; Blacher, J.; Hercberg, S. Effects of B Vitamins and omega 3 fatty acids on cardiovascular diseases: A randomized placebo controlled trial. BMJ 2010, 341, c6273.
148. Kwak, S.M.; Myung, S.K.; Lee, Y.J.; Seo, H.G.; Korean Meta-analysis Study Group. Efficacy of Omega-3 fatty acid supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the secondary prevention of cardiovascular disease: A meta-analysis of randomized, double-blind, placebo-controlled trials. Arch. Intern. Med. 2012, 172, 686-694.
149. Chowdhury, R.; Stevens, S.; Gorman, D.; Pan, A.; Warnakula, S.; Chowdhury, S.; Ward, H.; Johnson, L.; Crowe, F.; Hu, F.B.; et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: Systematic review and meta-analysis. BMJ 2012, 345, e6698.
150. Liu, T.; Korantzopoulos, P.; Shehata, M.; Li, G.; Wang, X.; Kaul, S. Prevention of atrial fibrillation with omega-3 fatty acids: A meta-analysis of randomised clinical trials. Heart 2011, 97, 1034-1040.
151. Rizos, E.C.; Ntzani, E.E.; Bika, E.; Kostapanos, M.S.; Elisaf, M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 2012, 308, 1024-1033.
152. Kromhout, D.; Yasuda, S.; Geleijnse, J.M.; Shimokawa, H. Fish oil and omega-3 fatty acids in cardiovascular disease: Do they really work? Eur. Heart J. 2012, 33, 436-443.
153. Lau, J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis 2006, 189, 19-30.
154. Moreau, R.A.; Whitaker, B.D.; Hicks, K.B. Phytosterols, phytostanols, and their conjugates in foods: Structural diversity, quantitative analysis, and health-promoting uses. Prog. Lipid Res. 2002, 41, 457-500.
155. Talati, R.; Sobieraj, D.M.; Makanji, S.S.; Phung, O.J.; Coleman, C.I. The comparative efficacy of plant sterols and stanols on serum lipids: A systematic review and meta-analysis. J. Am. Diet. Assoc. 2010, 110, 719-726.
156. Hansel, B.; Nicolle, C.; Lalanne, F.; Tondu, F.; Lassel, T.; Donazzolo, Y.; Ferrières, J.; Krempf, M.; Schlienger, J.L.; Verges, B.; et al. Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia. Am. J. Clin. Nutr. 2007, 86, 790-796.
157. Homma, Y.; Ikeda, I.; Ishikawa, T.; Taterno, M.; Sugano, M.; Nakamura, H. Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: A randomized, placebo-controlled trial. Nutrition 2003, 19, 369-374.
158. Nestel, P.; Cehun, M.; Pomeroy, S.; Abbey, M.; Eldon, G. Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods. Eur. J. Clin. Nutr. 2001, 55, 1084-1090.
159. Williams, C.L.; Bollella, M.C.; Strobino, B.A.; Boccia, L.; Campanaro, L. Plant stanol ester and bran fiber in childhood: Effects on lipids, stool weight and stool frequency in preschool children. J. Am. Coll. Nutr. 1999, 18, 572-581.
160. Lee, Y.M.; Haastert, B.; Scherbaum, W.; Hauner, H. A phytosterol-enriched spread improves the lipid profile of subjects with type 2 diabetes mellitus-A randomized controlled trial under free-living conditions. Eur. J. Nutr. 2003, 42, 111-117.
161. Demonty, I.; Ras, R.T.; van der Knaap, H.C.M.; Duchateau, G.S.M.J.E.; Meijer, L.; Zock, P.L.; Geleijnse, J.M.; Trautwein, E.A. Continuous dose-response relationship of the LDL-Cholesterol-Lowering effect of phytosterol intake. J. Nutr. 2009, 139, 271-284.
162. Blair, S.N.; Capuzzi, D.M.; Gottlieb, S.O.; Nguyen, T.; Morgan, J.M.; Cater, N.M. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am. J. Cardiol. 2000, 86, 46-52.
163. Ntanios, F.Y.; Jones, P.J.H. Dietary sitostanol reciprocally influences cholesterol absorption and biosynthesis in hamsters and rabbits. Atherosclerosis 1999, 143, 341-351.
164. Hendriks, H.F.; Brink, E.J.; Meijer, G.W.; Princen, H.M.; Ntanios, F.Y. Safety of long-term consumption of plant sterol esters-enriched spread. Eur. J. Clin. Nutr. 2003, 5, 681-692.
165. Gylling, H.; Puska, P.; Vartiainen, E.; Miettinen, T.A. Retinol, Vitamin D, carotenes and α-tocopherol in serum of a moderately hypercholesterolemic population consuming sitostanol ester margarine. Atherosclerosis 1999, 145, 279-285.
166. Noakes, M.; Clifton, P.; Ntanios, F.; Shrapnel, W.; Record, I.; McInerney, J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. J. Clin. Nutr. 2002, 75, 79-86.
167. Weingärtner, O.; Böhm, M.; Laufs, U. Controversial role of plant sterol esters in the management of hypercholesterolaemia. Eur. Heart J. 2009, 30, 404-409.